1. Home
  2. MLYS vs THS Comparison

MLYS vs THS Comparison

Compare MLYS & THS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • THS
  • Stock Information
  • Founded
  • MLYS 2019
  • THS 2021
  • Country
  • MLYS United States
  • THS United States
  • Employees
  • MLYS N/A
  • THS N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • THS Packaged Foods
  • Sector
  • MLYS Health Care
  • THS Consumer Staples
  • Exchange
  • MLYS Nasdaq
  • THS Nasdaq
  • Market Cap
  • MLYS 1.0B
  • THS 1.1B
  • IPO Year
  • MLYS 2023
  • THS N/A
  • Fundamental
  • Price
  • MLYS $13.67
  • THS $19.51
  • Analyst Decision
  • MLYS Strong Buy
  • THS Hold
  • Analyst Count
  • MLYS 4
  • THS 6
  • Target Price
  • MLYS $27.00
  • THS $23.67
  • AVG Volume (30 Days)
  • MLYS 692.8K
  • THS 603.8K
  • Earning Date
  • MLYS 08-12-2025
  • THS 07-31-2025
  • Dividend Yield
  • MLYS N/A
  • THS N/A
  • EPS Growth
  • MLYS N/A
  • THS N/A
  • EPS
  • MLYS N/A
  • THS 0.40
  • Revenue
  • MLYS N/A
  • THS $3,334,800,000.00
  • Revenue This Year
  • MLYS N/A
  • THS $1.10
  • Revenue Next Year
  • MLYS N/A
  • THS $1.65
  • P/E Ratio
  • MLYS N/A
  • THS $48.61
  • Revenue Growth
  • MLYS N/A
  • THS N/A
  • 52 Week Low
  • MLYS $8.24
  • THS $18.50
  • 52 Week High
  • MLYS $18.38
  • THS $43.84
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 45.18
  • THS 41.56
  • Support Level
  • MLYS $13.41
  • THS $18.50
  • Resistance Level
  • MLYS $15.15
  • THS $21.66
  • Average True Range (ATR)
  • MLYS 0.73
  • THS 0.94
  • MACD
  • MLYS 0.01
  • THS -0.05
  • Stochastic Oscillator
  • MLYS 25.36
  • THS 31.96

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About THS Treehouse Foods Inc.

TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages and drink mixes (such as nondairy creamer, coffee, tea, broth), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.

Share on Social Networks: